SubHero Banner
Text

April 2020

Core topics in this month’s edition include:

  • Bafiertam (monomethyl fumarate) – new drug approval
  • Ranitidine product market withdrawal
  • Singulair (montelukast sodium) safety update

Download PDF

Text